Figure 2. Effect of 1,25(OH)2D3 on the cell proliferation of PBMCs and CD4+ T cells from VKH patients and controls. A: Cell proliferation of PBMCs from active VKH patients (n=6) and normal controls (n=6) stimulated with 1,25(OH)2D3 of different concentrations. B: Cell proliferation of PBMCs from active VHK patients (n=11), inactive VHK patients (n=7) and normal controls (n=12) stimulated with or without 1,25(OH)2D3 (1×10⁻⁷mol/l). C: Cell proliferations of CD4+ T cells from active VHK patients (n=7), inactive VHK patients (n=7) and normal controls (n=9) stimulated with or without 1,25(OH)2D3 (1×10⁻⁷mol/l).